Financhill
Back

Apellis Pharmaceuticals Vs. Regencell Bioscience Holdings Industry Stock Comparison

Sell
36

APLS
Apellis Pharmaceuticals

Last Price:
$19.46
Seasonality Move:
-18.71%
Sell
22

RGC
Regencell Bioscience Holdings

Last Price:
$14.60
Seasonality Move:
-2.16%
Sell
36
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $19.44. The Score for APLS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Regencell Bioscience Holdings (RGC) is a Sell

Is Regencell Bioscience Holdings a Buy, Sell or Hold?

  • The current Regencell Bioscience Holdings [RGC] share price is $14.75. The Score for RGC is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • RGC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $19.44
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

RGC Stock Price Chart

What is Regencell Bioscience Holdings's stock price today?

  • The Regencell Bioscience Holdings share price today is $14.75
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGC is experiencing slight selling pressure.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.13 Buy
Relative Strength Index (14 RSI): 59.04 Buy
Chaikin Money Flow: 978928 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.71 - 19.21) Buy
Bollinger Bands (100): (17.13 - 24.01) Sell

RGC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.67 Buy
Relative Strength Index (14 RSI): 45.42 Sell
Chaikin Money Flow: -389367 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.8 - 41.2) Sell
Bollinger Bands (100): (-4.16 - 22.24) Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.43 Buy
20-day SMA: 18.24 Buy
50-day SMA: 18.24 Buy
200-day SMA: 25.42 Sell
8-day EMA: 18.68 Buy
20-day EMA: 18.39 Buy
50-day EMA: 18.83 Buy
200-day EMA: 25.83 Sell

RGC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.8 Sell
20-day SMA: 26.43 Sell
50-day SMA: 17.5 Sell
200-day SMA: 4.59 Buy
8-day EMA: 10.5 Buy
20-day EMA: 5.55 Buy
50-day EMA: 2.5 Buy
200-day EMA: 0.67 Buy

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.22 per share, and an increase next year of $0.74 per share.

Regencell Bioscience Holdings Earnings Growth & RGC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regencell Bioscience Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):